Article Versions Notes

Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Aggouraki D, Monastirioti A, Koutoulaki C, Apostolopoulou CA, Merodoulaki AC, Papadaki C, et al. Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer. Cancers. 2020; 12(2):376. https://doi.org/10.3390/cancers12020376

Papadaki, Maria A., Anastasios V. Koutsopoulos, Panormitis G. Tsoulfas, Eleni Lagoudaki, Despoina Aggouraki, Alexia Monastirioti, Chara Koutoulaki, Christina A. Apostolopoulou, Aikaterini C. Merodoulaki, Chara Papadaki, and et al. 2020. "Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer" Cancers 12, no. 2: 376. https://doi.org/10.3390/cancers12020376

Papadaki, M. A., Koutsopoulos, A. V., Tsoulfas, P. G., Lagoudaki, E., Aggouraki, D., Monastirioti, A., Koutoulaki, C., Apostolopoulou, C. A., Merodoulaki, A. C., Papadaki, C., Mavroudis, D., & Agelaki, S. (2020). Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer. Cancers, 12(2), 376. https://doi.org/10.3390/cancers12020376